- $514.30m
- $1.18bn
- $138.78m
- 40
- 59
- 51
- 48
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 103.76 | ||
PEG Ratio (f) | 2.69 | ||
EPS Growth (f) | 62.88% | ||
Dividend Yield (f) | 11.01% |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.96 | ||
Price to Tang. Book | 1.08 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 3.71 | ||
EV to EBITDA | 13.58 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 0.2% | ||
Return on Equity | 0.15% | ||
Operating Margin | 1.81% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 93.73 | 115.94 | 137.28 | 141.05 | 138.78 | 145.95 | 151.37 | 14.43% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | -41.08 | -97.95 | +1041.47 | +263.34 | -55.56 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Global Medical REIT Inc. is an internally managed real estate investment trust (REIT). The Company acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems. The Company conducts its business through a wholly owned subsidiary of its operating partnership, Global Medical REIT L.P. It owns 92.6% of the outstanding common operating partnership units (OP Units) of its operating partnership, with an aggregate of 7.4% of the Operating Partnership owned by holders of long-term incentive plan units (LTIP Units) and third-party limited partners who contributed properties or services to the operating partnership in exchange for OP Units. Its portfolio includes medical office buildings (MOBs), inpatient rehab. facility (IRF), surgical hospitals and others. The Company's portfolio is located in various areas, including Texas, Florida, Ohio, Pennsylvania, Illinois, Arizona, and Michigan.
Directors
- Jeffrey Busch CHM (64)
- Robert Kiernan CFO (55)
- Danica Holley COO (48)
- Alfonzo Leon CIN (45)
- Jamie Barber GCN (44)
- Henry Cole LED (76)
- Huiqi Zhang DRC (31)
- Paula Crowley IND (66)
- Matthew Cypher IND (44)
- Ronald Marston IND (78)
- Roscoe Moore IND (76)
- Lori Wittman IND (62)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- January 6th, 2014
- Public Since
- November 2nd, 2012
- No. of Shareholders
- 32
- No. of Employees
- 26
- Sector
- Residential & Commercial REITs
- Industry
- Financials
- Exchange
New York Stock Exchange
- Shares in Issue
- 66,878,728

- Address
- 7373 Wisconsin Avenue, Suite 800, BETHESDA, 20814
- Web
- https://www.globalmedicalreit.com/
- Phone
- +1 2025246851
- Contact
- Evelyn Infurna
- Auditors
- Deloitte & Touche LLP
Upcoming Events for GMRE
Q1 2025 Global Medical REIT Inc Earnings Call
Global Medical REIT Inc Annual Shareholders Meeting
Global Medical REIT Inc Annual Shareholders Meeting
Q2 2025 Global Medical REIT Inc Earnings Release
Similar to GMRE
Acadia Realty Trust
New York Stock Exchange
Acres Commercial Realty
New York Stock Exchange
AG Mortgage Investment Trust
New York Stock Exchange
Agree Realty
New York Stock Exchange
Alexander & Baldwin (Hawaii)
New York Stock Exchange
FAQ
As of Today at 20:51 UTC, shares in Global Medical REIT are trading at $7.69. This share price information is delayed by 15 minutes.
Shares in Global Medical REIT last closed at $7.69 and the price had moved by -4.94% over the past 365 days. In terms of relative price strength the Global Medical REIT share price has underperformed the S&P500 Index by -12.26% over the past year.
The overall consensus recommendation for Global Medical REIT is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Global Medical REIT dividend yield is 10.92% based on the trailing twelve month period.
Last year, Global Medical REIT paid a total dividend of $0.84, and it currently has a trailing dividend yield of 10.92%. We do not have any data on when Global Medical REIT is to next pay dividends.
We do not have data on when Global Medical REIT is to next pay dividends. The historic dividend yield on Global Medical REIT shares is currently 10.92%.
To buy shares in Global Medical REIT you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $7.69, shares in Global Medical REIT had a market capitalisation of $514.30m.
Here are the trading details for Global Medical REIT:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: GMRE
Based on an overall assessment of its quality, value and momentum Global Medical REIT is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Global Medical REIT is $10.47. That is 36.15% above the last closing price of $7.69.
Analysts covering Global Medical REIT currently have a consensus Earnings Per Share (EPS) forecast of $0.09 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Global Medical REIT. Over the past six months, its share price has underperformed the S&P500 Index by -11.8%.
As of the last closing price of $7.69, shares in Global Medical REIT were trading -12.02% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Global Medical REIT PE ratio based on its reported earnings over the past 12 months is 103.76. The shares last closed at $7.69.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Global Medical REIT's management team is headed by:
- Jeffrey Busch - CHM
- Robert Kiernan - CFO
- Danica Holley - COO
- Alfonzo Leon - CIN
- Jamie Barber - GCN
- Henry Cole - LED
- Huiqi Zhang - DRC
- Paula Crowley - IND
- Matthew Cypher - IND
- Ronald Marston - IND
- Roscoe Moore - IND
- Lori Wittman - IND